Predictors and outcomes of Mycobacterium tuberculosis bacteremia among patients with HIV and tuberculosis co-infection enrolled in the ACTG A5221 STRIDE study

We evaluated predictors and outcomes of Mycobacterium tuberculosis bacteremia among participants undergoing baseline mycobacterial blood culture in the ACTG A5221 STRIDE study, a randomized clinical trial comparing earlier with later ART among HIV-infected patients suspected of having tuberculosis w...

Full description

Saved in:
Bibliographic Details
Published in:BMC infectious diseases 2015-01, Vol.15 (1), p.12-12, Article 12
Main Authors: Crump, John A, Wu, Xingye, Kendall, Michelle A, Ive, Prudence D, Kumwenda, Johnstone J, Grinsztejn, Beatriz, Jentsch, Ute, Swindells, Susan
Format: Article
Language:English
Subjects:
Adult
Age Factors
Antiretroviral Therapy, Highly Active
Bacteremia - blood
Bacteremia - complications
Bacteremia - mortality
Care and treatment
CD4 Lymphocyte Count
Coinfection
Comparative analysis
Female
HIV Infections - complications
HIV Infections - drug therapy
HIV patients
HIV-1
Humans
Lymphocytes
Male
Middle Aged
Mycobacterium tuberculosis - isolation & purification
Patient outcomes
Sex Factors
South Africa - epidemiology
Survival Analysis
Tuberculosis, Pulmonary - complications
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We evaluated predictors and outcomes of Mycobacterium tuberculosis bacteremia among participants undergoing baseline mycobacterial blood culture in the ACTG A5221 STRIDE study, a randomized clinical trial comparing earlier with later ART among HIV-infected patients suspected of having tuberculosis with CD4-positive T-lymphocyte counts (CD4 counts)
ISSN:1471-2334
1471-2334
DOI:10.1186/s12879-014-0735-5